
CAS 85933-19-3
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 Produkte.
Carbidopa Related Compound A (3-O-Methylcarbidopa)
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFormel:C11H16N2O4Farbe und Form:Yellow Tan PowderMolekulargewicht:240.11101rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS:Formel:C11H16N2O4Molekulargewicht:240.26rac-Carbidopa EP Impurity C Trifluoroacetate (Carbidopa USP Related Compound A Trifluoroacetate)
CAS:Formel:C11H16N2O4·C2HF3O2Farbe und Form:White To Off-White SolidMolekulargewicht:240.26 114.02rac-Carbidopa EP Impurity C (Carbidopa USP Related Compound A)
CAS:Kontrolliertes ProduktFormel:C11H16N2O4Farbe und Form:NeatMolekulargewicht:240.263-O-Methyl Carbidopa
CAS:<p>Applications 3-O-Methylcarbidopa is an impurity of Carbidopa (C175915) with potential use as therapeutic agents to treat hypertension and Parkinson's disease.<br>References Gelber, L. et al.: J. Chrom., 257, 317 (1983); Kallwass, H. et al.: Bioorg. Med. Chem., 2, 557 (1994);<br></p>Formel:C11H16N2O4Farbe und Form:NeatMolekulargewicht:240.263-O-Methyl carbidopa
CAS:Kontrolliertes Produkt<p>3-O-Methyl carbidopa is a metabolite of L-3,4-dihydroxyphenylalanine that is used as a drug in the treatment of Parkinson's disease. 3-O-Methyl carbidopa is a racemic mixture of two stereoisomers that have different chemical properties. The (+) form is more active and has been shown to be more potent than the (-) form. Analysis of this compound by magnetic resonance spectroscopy (NMR) at different magnetic fields showed that it has six distinct resonances: three from the protonated molecule and three from the deprotonated molecule. The proton nmr spectrum showed peaks at 2.02 ppm (D1), 2.81 ppm (D2), 3.84 ppm (D3), 4.07 ppm (D4), 4.28 ppm (D5), and 4.53 ppm (D6). These peaks correspond to resonances for protons</p>Formel:C11H16N2O4Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:240.26 g/mol






